Results 181 to 190 of about 48,322 (288)

Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Patients hospitalized with acute heart failure (AHF) treated with a 7 day prednisone course in the CORTAHF pilot trial had a greater improvement in health‐related quality of life (QoL) at Day 7 in both the overall population and in patients with baseline interleukin 6 > 13 pg/mL.
Matteo Pagnesi   +21 more
wiley   +1 more source

Creativity and its link to epilepsy

open access: yesEpilepsia Open, EarlyView.
Abstract Creative thinking represents one of our highest‐order cognitive processes, involving multiple cortical structures and an intricate interplay between several cortical and subcortical networks. It results in novel ideas that translate to useful products or concepts. The evolutionary purpose of creativity is therefore apparent, as it advances our
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

On the Role of Psychometric Tests Played in Grasping Aphasic Symptoms

open access: bronze, 1986
波多野 和 夫   +4 more
openalex   +2 more sources

The Roter Interaction Analysis System (RIAS) in oncological consultations:: psychometric properties [PDF]

open access: green, 1998
L.M.L. Ong   +7 more
openalex   +1 more source

Subjective memory complaints in people with epilepsy: Are there “signature” complaints associated with anxiety and depression?

open access: yesEpilepsia Open, EarlyView.
Abstract Objective While there is a relatively weak association between cognitive complaints and performance on standardized tests of memory function, elevated levels of depression and anxiety are highly correlated with subjective memory complaints in people with epilepsy (PWE).
Cassandra Trend   +2 more
wiley   +1 more source

Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26‐Week Results From the Phase 3 PaTHway Trial

open access: yesJournal of Bone and Mineral Research, Volume 38, Issue 1, Page 14-25, January 2023., 2023
TransCon PTH is an investigational once‐daily prodrug providing sustained release of active PTH designed to maintain stable PTH levels in the physiological range for 24 hours/day. The PaTHway trial met all primary and key secondary endpoints with statistically significant differences from placebo. Most adverse events (AEs) were mild/moderate. Injection‐
Aliya A Khan   +19 more
wiley   +1 more source

EFFECTS OF SMALL CONCENTRATIONS OF ISOFLURANE ON SOME PSYCHOMETRIC MEASUREMENTS

open access: bronze, 1993
Junko Yoshizumi   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy